克利夫兰的制造工业根基或许已经衰老，但它今后的主要价值产品或许将换成心脏治疗技术。
Cleveland's manufacturing base may have declined, but its main commodity in future may be cardiac expertise.
虽然现在这项研究仅仅处于 原理验证阶段，但研究人员相信他们的技术最终能够发现一种手段，来替代一系列治疗心脏病的药物。
While the work currently remains just a proof-of-principle, the researchers believe that their technique could ultimately provide an alternative to drugs in treating a range of heart conditions.
安装一台血泵或人造心脏不太可能成为心脏疾病的主流治疗技术。
Installing a pump or an artificial heart is not likely to become mainstream treatment for heart disease.
但是，和机械泵以及人造心脏一样，干细胞疗法对于治疗心脏病来说也是一种高技术、高成本的解决方案。
But like mechanical pumps and artificial hearts, stem cell therapy is a high-tech, high-expense solution for dealing with heart diseases.
这一技术在保存移植器官和减少病人在心脏手术期间对含氧血液的需求方面用得很普及，不过，这一技术还没有在创伤病人的治疗上进行大范围的试验。
The technique is popular for preserving transplant organs and reducing the need for oxygenated blood during heart surgery, but it has not been widely tested in trauma patients.
本文详细报告了原位心脏移植的术前准备，手术技术，排斥反应的诊断和治疗，并结合文献加以讨论。
Preoperative preparation, surgical technique, diagnosis of rejection and immunosuppressive therapy for orthotopic heart transplantation were described and discussed in the paper.
这些专家知道如何操作那些用于医学特定分支领域的诊断和治疗仪器，但是他们也需要培训紧急干预技术，例如心脏复苏术。
These specialists know how to operate the diagnostic and treatment equipment used in that particular branch of medicine, but they are also trained in emergency intervention techniques such as CPR.
本研究为将来开发出一系列新的能特异性靶向心脏、用于治疗和诊断缺血性心肌病的方法打下了新的理论和技术基础。
Our findings have established the fundamental base in theory and technology for further tailor of the novel specific treatment and diagnosis methods in ischemic heart.
目的应用脉冲组织多普勒成像(PWDTI)技术评价急性心肌梗死(ami)后不同治疗方案对心脏整体及局部室壁功能的改变。
Objective To evaluate the local and whole function of different therapy in acute myocardial infarction (AMI) by pulsed-wave Doppler tissue imaging (PWDTI) with echocardiography.
利用磁导航技术辅助心脏介入治疗是目前世界最先进的创新性技术。
Magnetic navigation assisted cardiac interventions technique is the most advanced and innovative technology in the world.
这项技术已经过验证，并且显示它可有效预测心衰竭病患之传导障碍与左心室非同步异常对于心脏再同步治疗后之效果。
We have validated this technique and shown that it can reproducibly predict the response to CRT in patients with heart failure induced conduction disturbances and ventricular dyssynchrony.
本发明属于药品技术领域，涉及一种心脏病的治疗药物，特别涉及一种以中草药为原料制成的调节心衰的中药药物。
The present invention belongs to the field of medicine technology, and is especially one kind of heart failure treating Chinese medicine.
结论在技术成熟的心脏中心，PCI治疗CTO病变可获得较高的成功率和较好的临床效果。
Conclusion in an experienced heart center, it is possible to obtain a relatively high success rate of PCI and ideal clinical outcomes in patients with CTO coronary lesions.
通过加入2012世界心脏大会科学会议与您的同伴一同分项最新的治疗与预防技术。
Join your colleagues from across the globe at the WCC Scientific Sessions 2012 to share the latest science on treatment and prevention.
通过加入2012世界心脏大会科学会议与您的同伴一同分项最新的治疗与预防技术。
Join your colleagues from across the globe at the WCC Scientific Sessions 2012 to share the latest science on treatment and prevention.
应用推荐